Diclofenac epolamine (Flector) patch: evidence for topical activity

Area of Science:

• Pharmacology
• Clinical Medicine
• Drug Delivery Systems

Background:

• Diclofenac epolamine (diclofenac hydroxyethylpyrrolidine) patch is used for localized musculoskeletal pain.
• Previous studies indicate efficacy in conditions like osteoarthritis and ankle sprains.
• The mechanism of action, particularly topical vs. systemic effects, requires further clarification.

Purpose of the Study:

• To review clinical and pharmacokinetic data supporting a topical effect of the diclofenac epolamine patch.
• To demonstrate pain relief through local tissue accumulation of diclofenac.
• To assess the systemic safety profile of the diclofenac epolamine patch.

Main Methods:

• Review of previously unpublished clinical and pharmacokinetic data.
• Analysis of patient data from studies on knee osteoarthritis and ankle sprains.
• Pharmacokinetic analysis in healthy volunteers following single patch application.
• Evaluation of long-term safety data from 15 years of use.

Main Results:

• Significant pain reduction observed within hours of first patch application in osteoarthritis and ankle sprain patients.
• Diclofenac detected in plasma significantly later than pain relief onset, suggesting local action.
• Extended plasma half-life after patch application implies a tissue reservoir effect.
• Systemic bioavailability is low (~1%), with no reported systemic adverse effects like GI bleeding or ulcers.

Conclusions:

• The diclofenac epolamine patch provides effective pain relief for localized musculoskeletal conditions.
• Pain relief is attributed to local accumulation of diclofenac at the application site.
• The formulation demonstrates a favorable safety profile due to minimal systemic exposure.